Dr. Reddy’s, Aurigene, partner with Kainomyx for anti-malarial drug
Kainomyx will lead the technical strategy for drug discovery and clinical phases, Aurigene will focus on developing scalable drug chemistry and Dr. Reddy’s will advise on the regulatory and market access processes.